Cargando…
Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
Neuroinflammation contributes to the pathophysiology of various mental illnesses including schizophrenia. We investigated peripheral inflammatory cytokines as a biomarker for predicting symptomatic remission in patients with first-episode schizophrenia. The study included 224 patients aged 15–60 yea...
Autores principales: | Kim, Honey, Baek, Seon-Hwa, Kim, Ju-Wan, Ryu, Seunghyong, Lee, Ju-Yeon, Kim, Jae-Min, Chung, Young-Chul, Kim, Sung-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550944/ https://www.ncbi.nlm.nih.gov/pubmed/37794014 http://dx.doi.org/10.1038/s41537-023-00398-1 |
Ejemplares similares
-
Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
por: Baek, Seon-Hwa, et al.
Publicado: (2022) -
Association between suicidal ideation and cognitive function in young patients with schizophrenia spectrum disorder
por: Kim, Ji-Su, et al.
Publicado: (2023) -
S232. ASSOCIATIONS OF FOOD CRAVING WITH PSYCHOLOGICAL AND PHYSICAL CHARACTERISTICS IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS
por: Kim, Yeonghyeok, et al.
Publicado: (2020) -
Decline in Hospital Visits by Patients with Schizophrenia Early in the COVID-19 Outbreak in Korea
por: Ryu, Seunghyong, et al.
Publicado: (2022) -
Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder
por: Kim, Sung-Wan, et al.
Publicado: (2018)